An official website of the United States government.

This is not the current EPA website. To navigate to the current EPA website, please go to This website is historical material reflecting the EPA website as it existed on January 19, 2021. This website is no longer updated and links to external websites and some internal pages may not work. More information »

EPA’s Nonmonotonic Dose Response Curve Workplan

There are divergent positions in the scientific and regulatory communities regarding whether modifications to EPA’s standard guidelines for reproductive and developmental toxicity testing and risk assessment are needed in order to detect and characterize low-dose adverse effects of endocrine disrupting chemicals (EDCs).

You may need a PDF reader to view some of the files on this page. See EPA’s About PDF page to learn more.